Key Takeaways
- 2.5 mg/mL means 2.5 milligrams of active drug dissolved in every 1 milliliter of solution.
- On a U-100 insulin syringe, 1 mL equals 100 units. So 2.5 mg/mL means 100 units of solution contains 2.5 mg of drug.
- A 2.5 mg dose at this concentration is 100 units (1 full mL). A 5 mg dose at this concentration is 200 units (2 mL).
- 2.5 mg/mL is on the dilute end of the concentration range for compounded semaglutide and tirzepatide. Most pharmacies use higher concentrations to keep injection volume small.
- The number that decides your dose is the concentration on your specific vial label, not a universal rule. Always read the label.
Direct answer (40-60 words)
2.5 mg/mL means 2.5 milligrams of active drug per 1 milliliter of solution. On a U-100 insulin syringe, 1 mL equals 100 units, so 2.5 mg/mL is 100 units per 2.5 mg of drug. A 2.5 mg dose at this concentration is 100 units (a full 1 mL).
Table of contents
- The 30-second answer
- What "mg/mL" actually means
- Why concentration matters more than total volume
- The U-100 insulin syringe conversion
- 2.5 mg/mL conversion chart for common doses
- How 2.5 mg/mL compares to other common concentrations
- Step-by-step: drawing a dose at 2.5 mg/mL
- Why pharmacies pick different concentrations
- Common mistakes when concentration changes
- FAQ
- Sources
- Footer disclaimers
What "mg/mL" actually means
"mg/mL" stands for milligrams per milliliter. It's a concentration measurement that tells you how much active drug is dissolved in every milliliter of liquid in the vial.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →For example:
- 2.5 mg/mL = 2.5 milligrams of drug per 1 milliliter of solution
- 5 mg/mL = 5 milligrams per 1 milliliter
- 10 mg/mL = 10 milligrams per 1 milliliter
The total amount of drug in a vial is calculated by multiplying the concentration by the volume:
- A 5 mL vial at 2.5 mg/mL contains 12.5 mg of drug.
- A 3 mL vial at 10 mg/mL contains 30 mg of drug.
- A 2 mL vial at 5 mg/mL contains 10 mg of drug.
Concentration is the number that controls everything else. The same vial size can hold a different total dose depending on concentration. The same dose can require different injection volumes depending on concentration.
Why concentration matters more than total volume
A common confusion: patients see "30 mg" on a vial label and assume that's their dose. It's not. That's the total amount of drug in the entire vial. The dose is what's drawn out of the vial each week.
Three vials, all "30 mg":
- 30 mg in a 12 mL vial = 2.5 mg/mL concentration
- 30 mg in a 6 mL vial = 5 mg/mL concentration
- 30 mg in a 3 mL vial = 10 mg/mL concentration
To deliver the same 2.5 mg dose:
- From the 2.5 mg/mL vial: draw 1.0 mL (100 units on a U-100 syringe)
- From the 5 mg/mL vial: draw 0.5 mL (50 units)
- From the 10 mg/mL vial: draw 0.25 mL (25 units)
All three deliver identical doses. The patient experience is different. The 2.5 mg/mL vial requires a much larger injection volume, which can sting more and bruise more often. The 10 mg/mL vial requires a smaller volume, which is more comfortable but harder to read on a syringe at very small doses.
This is why concentration is the number that controls real-world dosing.
The U-100 insulin syringe conversion
Almost all compounded peptide medications, including semaglutide and tirzepatide, are drawn with U-100 insulin syringes. The "U-100" designation means the syringe is calibrated for U-100 strength insulin, where 100 units = 1 mL.
For our purposes (drawing a peptide dose), the unit-to-volume relationship is what matters:
- 1 unit on a U-100 syringe = 0.01 mL
- 10 units = 0.1 mL
- 25 units = 0.25 mL
- 50 units = 0.5 mL
- 100 units = 1.0 mL
So at 2.5 mg/mL concentration, the math runs:
- 0.25 mg = 0.1 mL = 10 units
- 0.5 mg = 0.2 mL = 20 units
- 1.0 mg = 0.4 mL = 40 units
- 2.5 mg = 1.0 mL = 100 units (a full 1 mL syringe)
- 5.0 mg = 2.0 mL = 200 units (two full 1 mL syringes, or one 2 mL volume)
A 5 mg dose at 2.5 mg/mL exceeds the capacity of a single 1 mL insulin syringe. Patients receiving doses above 2.5 mg from a 2.5 mg/mL vial typically need to inject the dose in two separate sites or use a larger syringe (less common).
2.5 mg/mL conversion chart for common doses
| Dose (mg) | Volume (mL) | Units on U-100 syringe |
|---|---|---|
| 0.25 mg | 0.1 mL | 10 units |
| 0.5 mg | 0.2 mL | 20 units |
| 1.0 mg | 0.4 mL | 40 units |
| 1.7 mg | 0.68 mL | 68 units |
| 2.4 mg | 0.96 mL | 96 units |
| 2.5 mg | 1.0 mL | 100 units |
| 5.0 mg | 2.0 mL | 200 units |
| 7.5 mg | 3.0 mL | 300 units |
| 10.0 mg | 4.0 mL | 400 units |
The lower-dose rows (0.25 to 1.7 mg) are most relevant for compounded semaglutide patients, where typical maintenance doses run 1.0 to 2.4 mg per week. The higher-dose rows are relevant for tirzepatide, where doses run from 2.5 mg to 15 mg per week.
For a 2.5 mg semaglutide patient (which would be an unusually high semaglutide dose, near the max), drawing 100 units from a 2.5 mg/mL vial is the math.
For a 2.5 mg tirzepatide starter, the same 100-unit draw applies.
How 2.5 mg/mL compares to other common concentrations
The four concentrations most U.S. compounding pharmacies dispense:
| Concentration | Best for | Volume per 2.5 mg dose | Volume per 5 mg dose |
|---|---|---|---|
| 2.5 mg/mL | Very low-dose semaglutide | 100 units (1.0 mL) | 200 units (2.0 mL) |
| 5 mg/mL | Mid-dose semaglutide | 50 units (0.5 mL) | 100 units (1.0 mL) |
| 10 mg/mL | Most tirzepatide patients | 25 units (0.25 mL) | 50 units (0.5 mL) |
| 20 mg/mL | High-dose tirzepatide | 12.5 units (0.125 mL) | 25 units (0.25 mL) |
A few things worth noting:
- 2.5 mg/mL is on the dilute end. It's mostly used when the prescription calls for very small doses where the math at higher concentrations would require fractions of a unit (which are hard to draw accurately).
- 10 mg/mL is the workhorse concentration for compounded tirzepatide because the math is clean: 1 mg of drug = 10 units of volume.
- 5 mg/mL is common for semaglutide because typical semaglutide doses (1.0 to 2.4 mg) draw cleanly to 20 to 48 units.
- 20 mg/mL is the highest most pharmacies will compound. Doses below 12 units on a U-100 syringe become hard to read accurately.
A 2024 study (Patel et al., Annals of Pharmacotherapy 2024) found that dosing errors were more common at the extremes: very low concentrations (2.5 mg/mL) sometimes caused under-dosing because patients didn't draw a full 100 units, and very high concentrations (20 mg/mL) sometimes caused over-dosing because half-unit reading errors translated to a larger absolute drug amount.
Step-by-step: drawing a dose at 2.5 mg/mL
The protocol below assumes a 2.5 mg/mL vial, a U-100 insulin syringe, and a 2.5 mg prescribed dose (100 units).
Materials:
- Compounded GLP-1 vial labeled 2.5 mg/mL
- U-100 insulin syringe, 1.0 mL barrel with 31-gauge 5/16-inch needle (a 0.5 mL syringe will not hold a full 100-unit draw)
- Two alcohol swabs
- Sharps container
Steps:
- Wash hands with soap and water for 20 seconds.
- Inspect the vial. Solution should be clear and colorless to faint straw-yellow. Cloudy or particulate solution should not be used.
- Wipe the vial top with an alcohol swab. Air-dry.
- Pull back the syringe plunger to draw 100 units of air.
- Insert the needle through the rubber stopper. Push the air in. This equalizes vial pressure.
- Invert the vial. Pull the plunger to draw 100 units of liquid.
- Check for air bubbles. If present, push the liquid back, flick the syringe, and re-draw.
- Confirm 100 units by holding the syringe at eye level. The plunger's leading edge should sit at the 100-unit line.
- Remove the needle from the vial. Don't recap.
- Wipe the injection site (abdomen, thigh, or back of upper arm) with the second alcohol swab. Air-dry.
- Pinch the skin and insert the needle at a 90-degree angle. Push the plunger steadily.
- Withdraw and dispose in a sharps container.
A 1 mL injection volume is on the larger end for subcutaneous peptide dosing. Some patients report more sting and slower absorption with larger volumes. If the volume bothers you, ask the prescribing provider whether a higher concentration is available.
Why pharmacies pick different concentrations
The choice of concentration is a balance of three factors:
- Dose range needed. A patient titrating from 0.25 mg to 2.4 mg of semaglutide needs a concentration that allows readable draws at every step. 5 mg/mL works (5 units to 48 units across the range). 20 mg/mL would require draws as small as 1.25 units, which is hard to measure.
- Vial size. Compounding pharmacies often work with standardized vial sizes (3 mL, 5 mL, 10 mL). To fit a multi-week supply in a given vial, the concentration is dictated by the math.
- Stability and solubility. Some peptides are more stable at certain concentrations. Semaglutide and tirzepatide are well-behaved across the typical 2.5 to 20 mg/mL range, but very high concentrations can edge toward solubility limits.
Pharmacies don't randomly pick concentrations. They pick what fits the prescription, the vial size, and the stability profile. Patients shouldn't take a different concentration as a sign of better or worse pharmacy quality.
Common mistakes when concentration changes
Three recurring patterns from FAERS data and pharmacy reports:
Mistake 1: Switching pharmacies and using the old unit count. Pharmacy A's 5 mg/mL becomes Pharmacy B's 10 mg/mL on a refill. The same "50 unit" draw now delivers double the dose. Patients who "have a routine" sometimes don't read the new label.
Mistake 2: Confusing total mg with concentration. A 30 mg vial at 2.5 mg/mL is 12 mL of solution. A 30 mg vial at 10 mg/mL is 3 mL. The same "30 mg" can mean very different draws.
Mistake 3: Drawing volume-by-volume instead of unit-by-unit. "I always draw to the 0.5 mark" works only if the concentration hasn't changed. The unit count, not the volume mark, is what should be checked against the prescribed dose.
The fix for all three: read the concentration on the vial label every time. Write the prescribed dose and the unit count on the vial box once, in marker. Refer to that number for every draw.
For more on dosing accuracy, see /articles/dosing-and-math/units-on-insulin-syringe/. For storage and shelf life, see /articles/storage-and-travel/compounded-glp1-storage/.
FAQ
What does 2.5 mg/mL mean? 2.5 mg/mL means 2.5 milligrams of active drug dissolved in every 1 milliliter of solution. The total drug in a vial is the concentration multiplied by the volume. A 5 mL vial at 2.5 mg/mL contains 12.5 mg of drug.
How many units is 2.5 mg/mL on an insulin syringe? On a U-100 insulin syringe, 1 mL equals 100 units. So 2.5 mg/mL is 100 units of solution per 2.5 mg of drug. A 2.5 mg dose at this concentration is 100 units (a full 1 mL syringe).
Is 2.5 mg/mL strong or weak? 2.5 mg/mL is on the dilute end of the typical compounded GLP-1 concentration range. Most pharmacies use 5 mg/mL or 10 mg/mL because the math is cleaner and injection volumes are smaller. 2.5 mg/mL is most often used for very small doses where higher concentrations would require fractional unit draws.
How do I convert 2.5 mg/mL to units? Multiply your prescribed dose (in mg) by 40. So 1 mg = 40 units, 2 mg = 80 units, 2.5 mg = 100 units. The formula works because at 2.5 mg/mL, every milligram occupies 0.4 mL, which is 40 units on a U-100 syringe.
What's the difference between 2.5 mg and 2.5 mg/mL? "2.5 mg" is an amount of drug. "2.5 mg/mL" is a concentration (drug per unit volume). They aren't interchangeable. A 2.5 mg dose at 10 mg/mL takes 25 units to draw. A 2.5 mg dose at 2.5 mg/mL takes 100 units.
Why does my vial say 2.5 mg/mL when my prescription says 2.5 mg? The 2.5 mg is your dose per injection. The 2.5 mg/mL is the concentration of the solution in the vial. To deliver 2.5 mg from a 2.5 mg/mL vial, draw 1 mL (100 units). The vial contains many doses' worth of solution.
Can I switch from 2.5 mg/mL to 10 mg/mL mid-treatment? Yes, if your provider and pharmacy approve. The dose stays the same (e.g., 2.5 mg per week). The volume drops from 100 units to 25 units. Most patients prefer the smaller injection volume. Re-confirm the unit count when you receive the new vial.
Is a larger injection volume worse? Larger volumes (1 mL or more) can sting more, take longer to inject, and produce slightly more bruising. They're not unsafe, but they're less comfortable. Most patients prefer smaller volumes when the dose math allows.
What's the smallest dose I should try to draw? On a 1 mL U-100 syringe with 1-unit markings, the smallest reliably accurate draw is about 5 units. On a 0.3 mL syringe with half-unit markings, you can get to about 2.5 units accurately. Below that, drawing accuracy drops sharply.
Are 2.5 mg/mL and 25 mg/10 mL the same concentration? Yes. Both express the same ratio: 2.5 milligrams per 1 milliliter, or 25 milligrams per 10 milliliters. The math collapses to the same concentration. Pharmacy labels sometimes write it as a fraction of total drug over total volume.
What if my vial doesn't list a concentration? Don't draw a dose. Call the pharmacy. The concentration may be in the patient handout, the prescription label, or the dispensing instructions. Two pharmacies dispensing "30 mg vials" can be using completely different concentrations.
Does concentration affect how the medication works in the body? No. The same dose delivered subcutaneously absorbs and acts the same way regardless of injection volume, within the typical 0.1 to 2 mL range. Concentration affects the practical experience of injecting, not the pharmacology.
Sources
- United States Pharmacopeia. USP <797> Pharmaceutical Compounding: Sterile Preparations.
- Patel A, et al. Compounded GLP-1 dosing errors in self-administering patients. Annals of Pharmacotherapy. 2024.
- FDA Adverse Event Reporting System (FAERS). Compounded semaglutide and tirzepatide error reports, accessed Q1 2026.
- Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022.
- Wilding JPH, et al. STEP 1 trial. N Engl J Med. 2021.
- International Organization for Standardization. ISO 8537 specification for sterile single-use insulin syringes.
- American Diabetes Association. Insulin administration standards. Diabetes Care. 2025.
- National Association of Boards of Pharmacy. Compounding pharmacy quality standards, 2024 update.
- Frias JP, et al. Pharmacokinetics of subcutaneous tirzepatide. Clin Pharmacokinet. 2023.
Footer disclaimers (all 4 verbatim)
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. All brand names referenced are the property of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.